Cargando…

Seroprevalence, seroconversion and seroreversion of Borrelia burgdorferi-specific IgG antibodies in two population-based studies in children and adolescents, Germany, 2003 to 2006 and 2014 to 2017

BACKGROUND: Lyme borreliosis (LB), caused by Borrelia burgdorferi (Bb), is the most common tick-borne infection in Germany. Antibodies against Bb are prevalent in the general population but information on temporal changes of prevalence and estimates of seroconversion (seroincidence) and seroreversio...

Descripción completa

Detalles Bibliográficos
Autores principales: Böhm, Stefanie, Woudenberg, Tom, Stark, Klaus, Böhmer, Merle M, Katz, Katharina, Kuhnert, Ronny, Schlaud, Martin, Wilking, Hendrik, Fingerle, Volker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451011/
https://www.ncbi.nlm.nih.gov/pubmed/37616114
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.34.2200855
_version_ 1785095332168728576
author Böhm, Stefanie
Woudenberg, Tom
Stark, Klaus
Böhmer, Merle M
Katz, Katharina
Kuhnert, Ronny
Schlaud, Martin
Wilking, Hendrik
Fingerle, Volker
author_facet Böhm, Stefanie
Woudenberg, Tom
Stark, Klaus
Böhmer, Merle M
Katz, Katharina
Kuhnert, Ronny
Schlaud, Martin
Wilking, Hendrik
Fingerle, Volker
author_sort Böhm, Stefanie
collection PubMed
description BACKGROUND: Lyme borreliosis (LB), caused by Borrelia burgdorferi (Bb), is the most common tick-borne infection in Germany. Antibodies against Bb are prevalent in the general population but information on temporal changes of prevalence and estimates of seroconversion (seroincidence) and seroreversion are lacking, especially for children and adolescents. AIM: We aimed at assessing antibodies against Bb and factors associated with seropositivity in children and adolescents in Germany. METHODS: We estimated seroprevalence via two consecutive cross-sectional surveys (2003–2006 and 2014–2017). Based on a longitudinal survey component, we estimated annual seroconversion/seroreversion rates. RESULTS: Seroprevalence was 4.4% (95% confidence interval (CI): 3.9–4.9%) from 2003 to 2006 and 4.1% (95% CI: 3.2–5.1%) from 2014 to 2017. Seroprevalence increased with age, was higher in male children, the south-eastern regions of Germany and among those with a high socioeconomic status. The annual seroconversion rate was 0.3% and the annual seroreversion rate 3.9%. Males were more likely to seroconvert compared with females. Low antibody levels were the main predictor of seroreversion. CONCLUSION: We did not detect a change in seroprevalence in children and adolescents in Germany over a period of 11 years. Potential long-term changes, for example due to climatic changes, need to be assessed in consecutive serosurveys. Seroconversion was more likely among children and adolescents than among adults, representing a target group for preventive measures. Seroreversion rates are over twice as high in children and adolescents compared with previous studies among adults. Thus, seroprevalence estimates and seroconversion rates in children are likely underestimated.
format Online
Article
Text
id pubmed-10451011
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-104510112023-08-26 Seroprevalence, seroconversion and seroreversion of Borrelia burgdorferi-specific IgG antibodies in two population-based studies in children and adolescents, Germany, 2003 to 2006 and 2014 to 2017 Böhm, Stefanie Woudenberg, Tom Stark, Klaus Böhmer, Merle M Katz, Katharina Kuhnert, Ronny Schlaud, Martin Wilking, Hendrik Fingerle, Volker Euro Surveill Research BACKGROUND: Lyme borreliosis (LB), caused by Borrelia burgdorferi (Bb), is the most common tick-borne infection in Germany. Antibodies against Bb are prevalent in the general population but information on temporal changes of prevalence and estimates of seroconversion (seroincidence) and seroreversion are lacking, especially for children and adolescents. AIM: We aimed at assessing antibodies against Bb and factors associated with seropositivity in children and adolescents in Germany. METHODS: We estimated seroprevalence via two consecutive cross-sectional surveys (2003–2006 and 2014–2017). Based on a longitudinal survey component, we estimated annual seroconversion/seroreversion rates. RESULTS: Seroprevalence was 4.4% (95% confidence interval (CI): 3.9–4.9%) from 2003 to 2006 and 4.1% (95% CI: 3.2–5.1%) from 2014 to 2017. Seroprevalence increased with age, was higher in male children, the south-eastern regions of Germany and among those with a high socioeconomic status. The annual seroconversion rate was 0.3% and the annual seroreversion rate 3.9%. Males were more likely to seroconvert compared with females. Low antibody levels were the main predictor of seroreversion. CONCLUSION: We did not detect a change in seroprevalence in children and adolescents in Germany over a period of 11 years. Potential long-term changes, for example due to climatic changes, need to be assessed in consecutive serosurveys. Seroconversion was more likely among children and adolescents than among adults, representing a target group for preventive measures. Seroreversion rates are over twice as high in children and adolescents compared with previous studies among adults. Thus, seroprevalence estimates and seroconversion rates in children are likely underestimated. European Centre for Disease Prevention and Control (ECDC) 2023-08-24 /pmc/articles/PMC10451011/ /pubmed/37616114 http://dx.doi.org/10.2807/1560-7917.ES.2023.28.34.2200855 Text en This article is copyright of the authors or their affiliated institutions, 2023. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Research
Böhm, Stefanie
Woudenberg, Tom
Stark, Klaus
Böhmer, Merle M
Katz, Katharina
Kuhnert, Ronny
Schlaud, Martin
Wilking, Hendrik
Fingerle, Volker
Seroprevalence, seroconversion and seroreversion of Borrelia burgdorferi-specific IgG antibodies in two population-based studies in children and adolescents, Germany, 2003 to 2006 and 2014 to 2017
title Seroprevalence, seroconversion and seroreversion of Borrelia burgdorferi-specific IgG antibodies in two population-based studies in children and adolescents, Germany, 2003 to 2006 and 2014 to 2017
title_full Seroprevalence, seroconversion and seroreversion of Borrelia burgdorferi-specific IgG antibodies in two population-based studies in children and adolescents, Germany, 2003 to 2006 and 2014 to 2017
title_fullStr Seroprevalence, seroconversion and seroreversion of Borrelia burgdorferi-specific IgG antibodies in two population-based studies in children and adolescents, Germany, 2003 to 2006 and 2014 to 2017
title_full_unstemmed Seroprevalence, seroconversion and seroreversion of Borrelia burgdorferi-specific IgG antibodies in two population-based studies in children and adolescents, Germany, 2003 to 2006 and 2014 to 2017
title_short Seroprevalence, seroconversion and seroreversion of Borrelia burgdorferi-specific IgG antibodies in two population-based studies in children and adolescents, Germany, 2003 to 2006 and 2014 to 2017
title_sort seroprevalence, seroconversion and seroreversion of borrelia burgdorferi-specific igg antibodies in two population-based studies in children and adolescents, germany, 2003 to 2006 and 2014 to 2017
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451011/
https://www.ncbi.nlm.nih.gov/pubmed/37616114
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.34.2200855
work_keys_str_mv AT bohmstefanie seroprevalenceseroconversionandseroreversionofborreliaburgdorferispecificiggantibodiesintwopopulationbasedstudiesinchildrenandadolescentsgermany2003to2006and2014to2017
AT woudenbergtom seroprevalenceseroconversionandseroreversionofborreliaburgdorferispecificiggantibodiesintwopopulationbasedstudiesinchildrenandadolescentsgermany2003to2006and2014to2017
AT starkklaus seroprevalenceseroconversionandseroreversionofborreliaburgdorferispecificiggantibodiesintwopopulationbasedstudiesinchildrenandadolescentsgermany2003to2006and2014to2017
AT bohmermerlem seroprevalenceseroconversionandseroreversionofborreliaburgdorferispecificiggantibodiesintwopopulationbasedstudiesinchildrenandadolescentsgermany2003to2006and2014to2017
AT katzkatharina seroprevalenceseroconversionandseroreversionofborreliaburgdorferispecificiggantibodiesintwopopulationbasedstudiesinchildrenandadolescentsgermany2003to2006and2014to2017
AT kuhnertronny seroprevalenceseroconversionandseroreversionofborreliaburgdorferispecificiggantibodiesintwopopulationbasedstudiesinchildrenandadolescentsgermany2003to2006and2014to2017
AT schlaudmartin seroprevalenceseroconversionandseroreversionofborreliaburgdorferispecificiggantibodiesintwopopulationbasedstudiesinchildrenandadolescentsgermany2003to2006and2014to2017
AT wilkinghendrik seroprevalenceseroconversionandseroreversionofborreliaburgdorferispecificiggantibodiesintwopopulationbasedstudiesinchildrenandadolescentsgermany2003to2006and2014to2017
AT fingerlevolker seroprevalenceseroconversionandseroreversionofborreliaburgdorferispecificiggantibodiesintwopopulationbasedstudiesinchildrenandadolescentsgermany2003to2006and2014to2017